| |
|
|
|
CymaBay Therapeutics Inc.  
|
|
12.82 -0.08 (-0.01%) |
05-24 09:52 |
|
Open: |
13 |
Pre close: |
12.9 |
Target:
|
15.83 
|
|
High: |
13.01 |
Low: |
12.76 |
Resistance:
|
13.55
15.83
|
|
Volume: |
309,266 |
Market Cap: |
881M |
Support:
|
12.36
11.63
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
12.56
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
12.78 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
11.44 |
Stochastic Oscillator |
%K(14,3):
|
54.35 |
|
MA(250): |
11.38 |
%D(3): |
47.33 |
|
Average Volume(K) |
3-Month: |
77613
|
52-Week |
High:
|
15.00 |
|
10-Days: |
105621 |
Low: |
6.31 |
|
RSI |
RSI(14):
|
52.47 |
Change(%): |
5.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.280 |
Return on Equity (ttm) |
-33.5 |
Shares Out. (M) |
68.69 |
|
EPS Est. Current Year |
-0.820 |
Return on Assets (ttm) |
-31.0 |
Shares Float (M) |
68.28 |
|
EPS Est. Next Year |
-0.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.460 |
EBITDA (p.s.) |
0.000 |
P/E |
-10.08 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.73 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-70.89 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-49.59 |
P/CF |
-12.50 |
|
|
|
|
|
|
